Editorial: Recent advances on the multimodal search for markers of treatment response in affective disorders: from bench to bedside, volume II.
作者信息
Walter Martin, Olbrich Sebastian, Opel Nils, Strauss Maria, Zhang Bin, Danyeli Lena Vera
机构信息
Department of Psychiatry, University Hospital Jena, Jena, Germany.
Department of Psychiatry, Psychiatric University Hospital Zurich, Zürich, Switzerland.
出版信息
Front Psychiatry. 2025 Aug 28;16:1597565. doi: 10.3389/fpsyt.2025.1597565. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Recent advances on the multimodal search for markers of treatment response in affective disorders: from bench to bedside, volume II.社论：情感障碍治疗反应标志物多模态研究的最新进展：从 bench 到 bedside，第二卷。 （注：这里“bench”和“bedside”在医学领域常分别表示基础研究和临床应用，直接保留英文表述更符合专业语境习惯）
Front Psychiatry. 2025 Aug 28;16:1597565. doi: 10.3389/fpsyt.2025.1597565. eCollection 2025.
2
Editorial: Recent Advances on the Multimodal Search for Markers of Treatment Response in Affective Disorders: From Bench to Bedside?社论：情感障碍治疗反应标志物多模态研究的最新进展：从 bench 到 bedside？ （注：这里“bench”和“bedside”在医学研究语境中有从基础研究到临床应用之意，直译为“从实验台到病床边”，这里意译使表达更符合中文习惯）
Front Psychiatry. 2019 Oct 30;10:790. doi: 10.3389/fpsyt.2019.00790. eCollection 2019.
3
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.马克 VCID 脑小血管联盟：一、入组、临床、液体方案。
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.
4
Noninvasive Multimodal Imaging and Its Role in Diagnosing Skin Lesions in Dermatology: A Systematic Review and Meta-Analysis.非侵入性多模态成像及其在皮肤科皮肤病变诊断中的作用：一项系统评价和荟萃分析。
Am J Clin Dermatol. 2025 Jul 8. doi: 10.1007/s40257-025-00958-4.
5
From bench to bedside: Examining the interpersonal and affective context of borderline personality disorder as it unfolds over time in psychotherapy.从实验室到临床：探讨边缘型人格障碍在心理治疗过程中随时间推移所呈现的人际与情感背景。
J Psychopathol Clin Sci. 2025 Jul 24. doi: 10.1037/abn0001032.
6
The development of type 2 diabetes management in people with severe mental illness in the Capital Region of Denmark from 2001 to 2015.丹麦首都大区 2001 至 2015 年期间严重精神疾病患者 2 型糖尿病管理的发展。
Acta Psychiatr Scand. 2024 Mar;149(3):219-233. doi: 10.1111/acps.13650. Epub 2024 Jan 6.
7
Screening for aspiration risk associated with dysphagia in acute stroke.筛查急性脑卒中吞咽困难相关的吸入风险。
Cochrane Database Syst Rev. 2021 Oct 18;10(10):CD012679. doi: 10.1002/14651858.CD012679.pub2.
8
Psychological therapies for treatment-resistant depression in adults.成人难治性抑郁症的心理治疗
Cochrane Database Syst Rev. 2018 May 14;5(5):CD010558. doi: 10.1002/14651858.CD010558.pub2.
9
Exercise therapy for chronic fatigue syndrome.慢性疲劳综合征的运动疗法
Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD003200. doi: 10.1002/14651858.CD003200.pub9.
10
Multimodal interventions for cachexia management.用于恶病质管理的多模式干预措施。
Cochrane Database Syst Rev. 2025 Mar 25;3(3):CD015749. doi: 10.1002/14651858.CD015749.pub2.
本文引用的文献
1
Effective Treatment for Mental and Substance Use Disorders in 21 Countries.21个国家针对精神和物质使用障碍的有效治疗方法。
JAMA Psychiatry. 2025 Apr 1;82(4):347-357. doi: 10.1001/jamapsychiatry.2024.4378.
2
A Systematic Evaluation of Machine Learning-Based Biomarkers for Major Depressive Disorder.基于机器学习的重度抑郁症生物标志物的系统评价
JAMA Psychiatry. 2024 Apr 1;81(4):386-395. doi: 10.1001/jamapsychiatry.2023.5083.
3
Heterogeneity in major depression and its melancholic and atypical specifiers: a secondary analysis of STAR*D.重性抑郁障碍及其忧郁和非典型特征的异质性：STAR*D 的二次分析。
BMC Psychiatry. 2021 Sep 16;21(1):454. doi: 10.1186/s12888-021-03444-3.
4
Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study.治疗前 qEEG 生物标志物预测重度抑郁症药物治疗效果：NeuroPharm 研究的独立验证。
Eur Neuropsychopharmacol. 2021 Aug;49:101-112. doi: 10.1016/j.euroneuro.2021.03.024. Epub 2021 Apr 25.
5
Linking atypical depression and insulin resistance-related disorders via low-grade chronic inflammation: Integrating the phenotypic, molecular and neuroanatomical dimensions.通过低水平慢性炎症将非典型抑郁症与胰岛素抵抗相关障碍联系起来：整合表型、分子和神经解剖学维度。
Brain Behav Immun. 2021 Mar;93:335-352. doi: 10.1016/j.bbi.2020.12.020. Epub 2020 Dec 23.
6
Depression Heterogeneity and Its Biological Underpinnings: Toward Immunometabolic Depression.抑郁的异质性及其生物学基础：走向免疫代谢性抑郁。
Biol Psychiatry. 2020 Sep 1;88(5):369-380. doi: 10.1016/j.biopsych.2020.01.014. Epub 2020 Jan 28.
7
Editorial: Recent Advances on the Multimodal Search for Markers of Treatment Response in Affective Disorders: From Bench to Bedside?社论：情感障碍治疗反应标志物多模态研究的最新进展：从 bench 到 bedside？ （注：这里“bench”和“bedside”在医学研究语境中有从基础研究到临床应用之意，直译为“从实验台到病床边”，这里意译使表达更符合中文习惯）
Front Psychiatry. 2019 Oct 30;10:790. doi: 10.3389/fpsyt.2019.00790. eCollection 2019.
8
Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practice.欧洲耐药性抑郁症研究组（GSRD）的研究结果——进一步研究和临床实践的基础。
World J Biol Psychiatry. 2019 Jul;20(6):427-448. doi: 10.1080/15622975.2019.1635270. Epub 2019 Jul 25.
9
Sex Specific Changes in Tryptophan Breakdown Over a 6 Week Treatment Period.六周治疗期内色氨酸分解的性别特异性变化。
Front Psychiatry. 2019 Feb 21;10:74. doi: 10.3389/fpsyt.2019.00074. eCollection 2019.
10
Quantitative Electroencephalography in Guiding Treatment of Major Depression.定量脑电图在重度抑郁症治疗指导中的应用
Front Psychiatry. 2019 Jan 23;9:779. doi: 10.3389/fpsyt.2018.00779. eCollection 2018.
Zotero 插件